Results 131 to 140 of about 18,020 (210)

RIPK1 protects epithelial cells [PDF]

Nature Reviews Molecular Cell Biology, 2014
openaire   +1 more source

RIPK1 wt Allele [PDF]

, 2020
openaire   +1 more source

Primary immunodeficiency reveals importance of RIPK1 [PDF]

Nature Reviews Rheumatology, 2018
openaire   +2 more sources

Development of a New Positron Emission Tomography Imaging Radioligand Targeting RIPK1 in the Brain and Characterization in Alzheimer's Disease

Advanced Science
Targeting receptor‐interacting protein kinase 1 (RIPK1) has emerged as a promising therapeutic stratagem for neurodegenerative disorders, particularly Alzheimer's disease (AD).
Ping Bai, Yu Lan, Yan Liu, Prasenjit Mondal, Ashley Gomm, Yulong Xu, Yanli Wang, Yongle Wang, Leyi Kang, Lili Pan, Frederick A. Bagdasarian, Madelyn Hallisey, Fleur Lobo, Breanna Varela, Se Hoon Choi, Stephen N. Gomperts, Hsiao‐Ying Wey, Shiqian Shen, Rudolph E. Tanzi, Changning Wang, Can Zhang   +20 more
doaj   +1 more source

Cell death: RIPK1 protects epithelial cells [PDF]

Nature Reviews Molecular Cell Biology, 2014
openaire   +2 more sources

RIPK1 inhibition mitigates neuroinflammation and rescues depressive-like behaviors in a mouse model of LPS-induced depression

Cell Communication and Signaling
Background Depression is often linked to inflammation in the brain. Researchers have been exploring ways to reduce this inflammation to improve depression symptoms.
Qichao Gong, Tahir Ali, Yue Hu, Ruyan Gao, Shengnan Mou, Yanhua Luo, Canyu Yang, Axiang Li, Tao Li, Liang Liang Hao, Liufang He, Xiaoming Yu, Shupeng Li   +12 more
doaj   +1 more source

Serum Level of RIPK1/3 Correlated With the Prognosis in ICU Patients With Acute Ischemic Stroke

Immunity, Inflammation and Disease
Background Acute ischemic stroke (AIS) is a common cerebrovascular disease with high mortality. AIS patients in the intensive care unit (ICU) often have severe conditions that require close monitoring and timely treatment.
Jianhong Dong, Xinli Xiong
doaj   +1 more source

miR-3921 functions as a tumor suppressor and negatively regulates RIPK1 in gastric cancer. [PDF]

PeerJ
Xu C, Long Z, Li X, Liu P.
europepmc   +1 more source

RIPK1 as a potential target to augment DC efficacy in tumor immunotherapy. [PDF]

Cancer Immunol Immunother
Mao L, Ou Y, Zhang Y, Wang M, Dong G, Khanniche A, Wang H, Wu Z, Zhang H, Hu L, Kong X.   +10 more
europepmc   +1 more source

USP25 regulates atherosclerosis by restricting RIPK1-mediated inflammatory responses. [PDF]

EBioMedicine
Su X, Zhou B, Xu Y, Du X, Chen J, Yin M, Miao X, Zhao Y, Wang D, Zhu Z, Li Z, Cai F, Wang W, Wu G, Huang J, Song W, Wang X.   +16 more
europepmc   +1 more source